Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Oral Minoxidil for Permanent Chemotherapy-Induced Alopecia
NCT03831334Phase 1Completed
- Sponsor
- Northwestern University
- Start
- Apr 2019
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of minoxidil in Chemotherapy-induced alopecia (CIA), sponsored by Northwestern University. Primary endpoints: Investigator's Photographic Assessment Questionnaire scale at 48 weeks and Dean Scale at 48 weeks. Started Apr 2019; status: completed.
02
Drugs
minoxidil
03
Conditions
Chemotherapy-induced alopecia (CIA)
Beyond the preview
Go deeper on NCT03831334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03831334.